SCHEMBL362747

SCHEMBL362747

CCCCC(CC)CNC(=O)CC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.52
ALDH1A1 P00352 5/20 0.52
CYP3A4 P08684 2/20 0.52
HTT P42858 3/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
POLB P06746 1/20 0.48
MAPK1 P28482 1/20 0.48
GLA P06280 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CA2 P00918 2/20 0.44
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
ATM Q13315 1/20 0.41
HRH4 Q9H3N8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3501512 0.98 TSHR (0.50) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL16312317 0.91 TSHR (0.57) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL12180618 0.86 TSHR (0.52) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL8515067 0.85 TSHR (0.55) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL8600740 0.85 TSHR (0.55) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL10644460 0.84 TSHR (0.50) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL14836356 0.84 TSHR (0.53) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL1165645 0.84 TSHR (0.53) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL11663143 0.84 TSHR (0.53) TSHRALDH1A1CYP3A4HTTLMNA
SCHEMBL18638052 0.83 TSHR (0.57) TSHRALDH1A1CYP3A4HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 528 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152464-A1 Composition Comprising Microcapsules PROCTER & GAMBLE (US) 2017-06-01 US claimed
EP-3080610-A1 UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE University of Houston System (US) 2016-10-19 EP claimed
CN-106030309-A Universal antigen retrieval compounds and methods of use thereof 休斯敦大学系统 2016-10-12 CN claimed
EP-2350247-B1 LIQUID HARD SURFACE CLEANING COMPOSITION PROCTER & GAMBLE (US) 2016-04-20 EP claimed
US-20150168417-A1 Universal Antigen Retrieval Compounds and Methods of Use UNIVERSITY OF HOUSTON SYSTEM (US) 2015-06-18 US claimed
WO-2015088667-A1 UNIVERSAL ANTIGEN RETRIEVAL COMPOUNDS AND METHODS OF USE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-06-18 WO claimed
CN-102171325-B Composition comprising microcapsules PROCTER & GAMBLE 2014-06-25 CN claimed
US-8664174-B2 Composition comprising microcapsules THE PROCTER & GAMBLE COMPANY (US) 2014-03-04 US claimed
US-8569223-B2 Liquid hard surface cleaning composition THE PROCTER & GAMBLE COMPANY (US) 2013-10-29 US claimed
US-8551932-B2 Liquid hard surface cleaning composition THE PROCTER & GAMBLE COMPANY (US) 2013-10-08 US claimed
US-20100081606-A1 LIQUID HARD SURFACE CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY 2010-04-01 US claimed
US-20100081604-A1 LIQUID HARD SURFACE CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY 2010-04-01 US claimed
EP-2169042-A1 Composition comprising microcapsules The Procter and Gamble Company (US) 2010-03-31 EP claimed
CN-101379176-A Fabric care compositions comprising formaldehyde scavengers PROCTER & GAMBLE (US) 2009-03-04 CN claimed
EP-1991648-A1 FABRIC CARE COMPOSITIONS COMPRISING FORMALDEHYDE SCAVENGERS The Procter and Gamble Company (US) 2008-11-19 EP claimed
EP-1983032-A1 Phase change inks containing colorant compounds Xerox Corporation (US) 2008-10-22 EP claimed
EP-1980593-A2 Colourant compounds for phase change inks Xerox Corporation (US) 2008-10-15 EP claimed
US-20080245264-A1 Phase change inks containing colorant compounds XEROX CORPORATION. 2008-10-09 US claimed
US-20070191256-A1 Fabric care compositions comprising formaldehyde scavengers PROCTER & GAMBLE COMPANY, THE 2007-08-16 US claimed
WO-2007091223-A1 FABRIC CARE COMPOSITIONS COMPRISING FORMALDEHYDE SCAVENGERS THE PROCTER & GAMBLE COMPANY (US) 2007-08-16 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081604-A1 LIQUID HARD SURFACE CLEANING COMPOSITION SETD7, FLNA, SETD2 TSHR 2683/4885ALDH1A1 1965/4885CYP3A4 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.